Matarin Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-72,004
Closed -$6.25M 226
2019
Q4
$6.25M Sell
72,004
-1,484
-2% -$122K 0.6% 65
2019
Q3
$5.9M Sell
73,488
-115
-0.2% -$9.22K 0.45% 88
2019
Q2
$5.89M Hold
73,603
0.42% 87
2019
Q1
$5.84M Sell
73,603
-90
-0.1% -$6.73K 0.42% 89
2018
Q4
$5.37M Buy
+73,693
New +$5.2M 0.43% 83

Other funds holding MRK

Matarin Capital Management's MRK Position: Q1 2020 in Review

Matarin Capital Management sold out of Merck (MRK) in Q1 2020, closing a stake of 72,004 shares — an estimated $6.25M sold.

Matarin Capital Management first reported a position in MRK in Q4 2018 and held it in 5 quarters. The position peaked at $6.25M in Q4 2019. 2,478 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • Matarin Capital Management reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
  • Matarin Capital Management sold 72,004 Merck shares in Q1 2020, an estimated $6.25M.
  • Matarin Capital Management first reported a position in Merck in Q4 2018 and held it in 5 quarters.
  • Matarin Capital Management's Merck position peaked at $6.25M in Q4 2019.
  • 2,478 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Matarin Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.